AGENUS INC — Director's Dealing 2011

Jan 5, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2011-01-04

Reporting Person: KLASKIN CHRISTINE M (VP, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-04	Stock Option, right to buy	$1.05	A	40000	Acquired	2021-01-04	Common Stock (40000)	Direct
2011-01-04	Restricted Stock	$	A	30000	Acquired	2013-07-04	Common Stock (30000)	Direct

Footnotes

F1: Options granted in accordance with the Antigenics Inc. 2009 Equity Incentive Plan and vests quarterly over three years beginning April 4, 2011.

F2: Restricted stock granted in accordance with the Antigenics Inc. 2009 Equity Incentive Plan and vests based on the achievement of performance milestones as determined by the Compensation Committee of the Board of Directors of Antigenics Inc.